Aims: To test the hypothesis that deficient a smooth muscle actin (ASMA) expression in intestinal smooth muscle, as assessed by immunohistochemistry, is specifically associated with clinical evidence of intestinal pseudo-obstruction. Methods: Seventeen archival, formalin fixed, paraffin wax embedded samples of small intestine and 12 samples of large intestine were studied. Two of the small bowel samples and one large bowel sample were from patients with symptoms of intestinal pseudo-obstruction. The controls were longitudinal surgical margins from hemicolectomies performed for carcinoma. Immunohistochemistry was performed using primary antibodies to ASMA, smooth muscle myosin heavy chain (SMMHC), and desmin. The relative intensities of immunohistochemical expression in the circular and longitudinal muscle layers of the muscularis propria were assessed in each sample, for all three markers. Results: All samples showed strong SMMHC and desmin expression in the inner circular and outer longitudinal layers of the muscularis propria. Both small intestinal samples from the cases and 11 of 15 controls showed no or minimal ASMA expression in the inner circular layer, with the remaining four controls also showing ASMA labelling in this layer that was weaker than within the longitudinal muscle. In contrast, intense ASMA expression was seen in both muscle layers within the large intestine in the remaining case, and in the controls. Conclusions: There is insufficient evidence from this study to support the hypothesis that ASMA deficiency in intestinal smooth muscle, as determined by immunohistochemistry on archival tissues, is specifically associated with intestinal pseudo-obstruction.
T he normal motility of the gastrointestinal tract relies on coordinated neuromuscular function, the loss of which results in abnormal bowel transit as a result of altered motility. 1 Six distinct actin filament isoforms have been described, of which the best known is a smooth muscle actin (ASMA). Actins of various isoforms are widely expressed but are not always involved in cellular contraction. 2 In contrast, mature intestinal smooth muscle expresses mainly ASMA and c smooth muscle actin. 3 The term ''chronic intestinal pseudo-obstruction'' refers to a clinical syndrome of recurrent intestinal obstruction caused by nerve or muscle dysfunction. 1 Myopathies may affect the intestine in a segmental, multifocal, or diffuse manner. 4 Malnutrition may result from untreated disease. 5 ''The term chronic intestinal pseudo-obstruction refers to a clinical syndrome of recurrent intestinal obstruction caused by nerve or muscle dysfunction''
In many cases of intestinal pseudo-obstruction, abnormalities may not be visible in routine haematoxylin and eosin stained sections, and additional histochemical, immunohistochemical, and ultrastructural examinations may be needed for a more precise diagnosis. In 1992, Smith et al described the case of a woman who had experienced chronic constipation since early childhood, and who had intestinal pseudoobstruction associated with the absence, as detected using immunostaining on frozen tissue, of ASMA within the intestinal circular muscle, with no abnormalities in other contractile proteins or morphological changes identified by light microscopy or ultrastructural examination. 6 This finding has been subsequently classified as a cause of primary congenital/early onset intestinal myopathy, as a primary specific contractile protein abnormality in apparently normal smooth muscle. 3 In our study, we have tested the hypothesis that chronic intestinal pseudo-obstruction is specifically associated with deficient ASMA expression within the inner circular layer of the intestinal muscularis propria, as assessed using immunohistochemistry on formalin fixed and paraffin wax embedded material.
METHODS
Three patients with intestinal pseudo-obstruction were studied. In two patients, the small intestinal wall was available and in the third case, a sample of the large intestine was studied. Case 1 was a 41 year old woman with an eight year history of abdominal pain, in whom small bowel dysmotility had been diagnosed after manometry studies, and who had previously undergone right hemicolectomy for a caecal volvulus. Case 2 was a 28 year old woman with a clinical diagnosis of small intestinal dysmotility, who underwent laparoscopy and full thickness ileal biopsy. Case 3 was a 54 year old woman with a history of chronic constipation since adolescence and a clinical diagnosis of pseudo-obstruction who underwent subtotal colectomy. No mechanical cause for bowel obstruction was identified within the resection specimens.
Control material was sourced from archival resections from 15 patients undergoing right hemicolectomy for caecal or proximal colonic carcinoma. Once suboptimally orientated sections had been excluded, a total of 15 small intestine samples and 11 large intestine samples served as controls.
Abbreviations: ASMA, a smooth muscle actin; SMMHC, smooth muscle myosin heavy chain
In all cases and controls, histological examination revealed morphologically normal submucosal and myenteric nerve plexuses and muscularis propria smooth muscle. In particular, the muscularis propria smooth muscle showed no evidence of muscle layer loss, inflammation, fibrosis, or inclusion bodies using haematoxylin and eosin and diastaseperiodic acid Schiff staining.
Formalin fixed and paraffin wax embedded sections of tissues were cut at 4 mm, dewaxed, and rehydrated in xylene and ethanol before antigen retrieval. Using the standard avidin-biotin-peroxidase complex staining technique, immunohistochemical staining was performed on all of the cases using the following primary antibodies: monoclonal anti-ASMA (clone 1A4; Sigma, Poole, Dorset, UK) at a 1/200 dilution, monoclonal anti-SMMHC (Dako, High Wycombe, UK) at a 1/200 dilution, and monoclonal anti-desmin (ICN Biomedicals, Basingstoke, UK) at a 1/30 dilution. For each sample, an adjacent tissue section was included without primary antibody as a negative control.
Endogenous peroxidase was inhibited using 0.5% hydrogen peroxide in methanol. The sections were then rinsed in buffer at pH 7.6. For ASMA and SMMHC, antigen retrieval was performed by placing the sections in a citrate buffer (0.01M citric acid with 80 g of sodium hydroxide/litre, adjusted to pH 6.0). Sections to be stained for ASMA were heated in a microwave oven (Panasonic NN-5452, 800 Watts, seven minutes at high power and seven minutes at medium power) and those for SMMHC were pressure cooked (Tefal CLIP50 X-PRESS at 13 lb pressure for two minutes). Sections to be stained with desmin were not subjected to antigen retrieval but were treated with 1% bovine serum albumin for 30 minutes. The sections were incubated with the primary antibody: at room temperature for 30 minutes in the case of ASMA and desmin, and for 24 hours at 4˚C for SMMHC. After rinsing the sections in buffer, immunoreactivity was demonstrated using the LSAB kit (Dako), followed by 3-39 diaminobenzidine-hydrogen peroxide solution. The slides were counterstained with haematoxylin, dehydrated, and mounted.
Each section was assessed by comparing the intensity of immunohistochemical labelling within the circular and longitudinal muscle layers of the muscularis propria, for each of the primary antibodies. Immunoreactivity within the muscularis mucosa and vessel walls acted as positive internal controls. Each section was scored independently by two consultant gastrointestinal pathologists (ACB and NJC). Table 1 summarises the results. The small intestinal samples from cases 1 and 2 and from controls 1-11 showed absent or minimal ASMA expression within the inner circular layer of the muscularis propria, with the exception of the innermost layer adjacent to the submucosa, where intense expression was present (fig 1A, B) . Intense ASMA expression was present throughout the outer longitudinal muscle, muscularis mucosa, and vessel walls. In controls 12-15, small intestinal circular muscle ASMA expression was assessed as weak-there was slightly less intense expression within the inner circular muscle compared with the longitudinal muscle or the innermost circular muscle ( fig 1C) . The large intestinal sample from patient 3 showed equally intense ASMA expression within the inner circular and outer longitudinal layers of the muscularis propria ( fig 1D) .
RESULTS
All cases and controls showed equally intense desmin and SMMHC expression within the inner circular and outer longitudinal muscle layers of the muscularis propria, muscularis mucosa, and vessel walls, within both the small and large intestine (fig 1E-H) .
DISCUSSION
We have demonstrated absent or minimal ASMA expression within the inner circular smooth muscle layer of the small intestinal muscularis propria in two cases of intestinal pseudo-obstruction and in most of our controls. This pattern of ASMA expression is the same as that described by Smith et al in a case of intestinal pseudo-obstruction. 6 However, those authors did not find a lack of ASMA expression in control cases in which there was no history of pseudo-obstruction.
Our study and that of Smith et al found intense ASMA expression within the innermost circular muscle layer, even when expression in the remainder of the inner circular layer was absent. Smith et al suggested that this phenomenon might be related to the embryological development of the intestine being similar to that of rats, where the development of the innermost circular muscle layer appears as a distinct cell layer of actin positive cells in the perinatal period. ''Our study and that of Smith et al found intense a smooth muscle actin expression within the innermost circular muscle layer, even when expression in the remainder of the inner circular layer was absent'' Our study and that of Smith et al used the same monoclonal antibody, specific for a single isoform of 
